OvCa-Chip microsystem recreates vascular endothelium–mediated platelet extravasation in ovarian cancer
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
In ovarian cancer, platelet extravasation into the tumor and resulting metastasis is thought to be regulated mostly by the vascular endothelium. Because it is difficult to dissect complex underlying events in murine models, organ-on-a-chip methodology is applied to model vascular and platelet functions in ovarian cancer. This system (OvCa-Chip) consists of microfluidic chambers that are lined by human ovarian tumor cells interfaced with a 3-dimensional endothelialized lumen. Subsequent perfusion with human platelets within the device's vascular endothelial compartment under microvascular shear conditions for 5 days uncovered organ-to-molecular-level contributions of the endothelium to triggering platelet extravasation into tumors. Further, analysis of effluents available from the device's individual tumor and endothelial chambers revealed temporal dynamics of vascular disintegration caused by cancer cells, a differential increase in cytokine expression, and an alteration of barrier maintenance genes in endothelial cells. These events, when analyzed within the device over time, made the vascular tissue leaky and promoted platelet extravasation. Atorvastatin treatment of the endothelial cells within the OvCa-Chip revealed improved endothelial barrier function, reduction in inflammatory cytokines and, eventually, arrest of platelet extravasation. These data were validated through corresponding observations in patient-derived tumor samples. The OvCa-Chip provides a novel in vitro dissectible platform to model the mechanisms of the cancer-vascular-hematology nexus and the analyses of potential therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Ovarian (metastasis) | Saha et al. (2020) | Microfluidic device with 2 parallel chambers | HUVECs, platelets, A2780, HOMECs, OVCAR3 | Influence on vascular luminal microenvironment and platelet extravasation |”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Saha et al., 2020
In the citing paper
“Since the mechanism of how platelets traffic and extravasate into the tumor is poorly understood, Saha and colleagues performed a proof-of-concept study showing that platelet extravasation can be modeled in the context of microfluidic chips (Saha et al., 2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Saha et al., 2020
In the citing paper
“Further, the researchers were able to show that the increased expression of cytokines (IL-8, MCP-1, IL-6, and TNF-α) by the cancer cells led to endothelial adhesion junction degradation, increased gap formation and loss of endothelial barrier function that was accompanied by the activation of the Src/ERK/FAK signaling pathway and downregulation of the vascular barrier regulators VE-cadherin and VE”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Saha et al., 2020
In the citing paper
“These findings were consistent across five patient samples of the HGSOC type, indicating the potential of atorvastatin as a vasculature-normalizing drug that limits platelet extravasation and indirectly influences tumor metastasis.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Saha et al., 2020
In the citing paper
“Upon perfusion, platelets adhered to cancer-interacting ECs, extravasated and colonized into tumors; mirroring in vivo observations.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Saha et al., 2020
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305 · cited 1×
“An organ chip is a microfluidic cell culture platform with multicellular compartments that mimic the tissue-tissue interface and the mechanical forces that govern biological function.(13) This platform offers an in vitro tool for studying how cells and molecules work alone or in combination to influence human disease…”
BackgroundKureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
Carmeliet, P., Lampugnani, M.-G., Moons, L., Breviario, F., Compernolle, V., Bono, F., Balconi, G., Spagnuolo, R., Oosthuyse, B., Dewerchin, M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81010-7 · Cited by 1,283 · cited 1×
“Correspondingly, we found a significant downregulation in the expression of the VE-cadherin and b-catenin genes, as well as VE-PTP (VEcadherin/b-catenin assembly), the master regulators of vascular barrier function.(9,35,36) We also found an increased expression of endothelial Akt in the presence of ovarian cancer cel…”
BackgroundDimmeler, S., Aicher, A., Vasa, M., Mildner-Rihm, C., Adler, K., Tiemann, M., Rütten, H., Fichtlscherer, S., Martin, H., & Zeiher, A. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13152 · Cited by 1,211 · cited 1×
“Some prior studies have shown that statins activate Akt to promote angiogenesis and regeneration.(40,41) Corresponding to these studies, our model showed that Akt expression in a drug OvCaChip was further increased, and endothelial Akt was more highly activated relative to that in the OvCa-Chip.”
BackgroundDimmeler, S., Aicher, A., Vasa‐Nicotera, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113152 · Cited by 1,025
Paraneoplastic thrombocytosis in ovarian cancer
Stone, R. L., Nick, A. M., McNeish, I. A., Balkwill, F., Han, H. D., Bottsford-Miller, J., Rupaimoole, R., Armaiz-Pena, G. N., Pecot, C. V., Coward, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110352 · Cited by 812
Self-citationHuman 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation
Jeon, J. S., Bersini, S., Gilardi, M., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417115112 · Cited by 723
Microfabrication of human organs-on-chips
Huh, D., Kim, H. J., Fraser, J. P., Shea, D. E., Khan, M., Bahinski, A., Hamilton, G. A., & Ingber, D. E. (2013) · Nature Protocols · doi:10.1038/nprot.2013.137 · Cited by 712 · cited 1×
“Methods OvCa-Chip design and tissue culture The microchip was designed and fabricated by using a previously described protocol.(21) In brief, 2 microfluidic chambers (adjacent parallel tumor channel and blood vessel channel) were formed (top tumor channel: 400mmwide, 100mmhigh; bottom vascular channel: 400mm wide, 100…”
MethodTaddei, A., Giampietro, C., Conti, A., Orsenigo, F., Breviario, F., Pirazzoli, V., Potente, M., Daly, C., Dimmeler, S., & Dejana, E. (2008) · Nature Cell Biology · doi:10.1038/ncb1752 · Cited by 653 · cited 1×
“Correspondingly, we found a significant downregulation in the expression of the VE-cadherin and b-catenin genes, as well as VE-PTP (VEcadherin/b-catenin assembly), the master regulators of vascular barrier function.(9,35,36) We also found an increased expression of endothelial Akt in the presence of ovarian cancer cel…”
BackgroundRho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase
Takemoto, M., Sun, J., Hiroki, J., Shimokawa, H., & Liao, J. K. (2002) · Circulation · doi:10.1161/01.cir.0000020682.73694.ab · Cited by 475 · cited 2×
“This relieves the inflammation-induced suppression of eNOS mRNA synthesis and therefore increases the production and bioavailability of endothelium-derived NO.(45,46) Therefore, the r/ROCK pathways may be a downstream contributor to the pleiotropic effects of statin and may be an important mechanism that also plays a…”
Background
Cited by
Bioengineering trends in female reproduction: a systematic review
Francés‐Herrero, E., Lopez, R., Hellström, M., de Miguel–Gómez, L., Herraiz, S., Brännström, M., Pellicer, A., & Cervelló, I. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac025 · Cited by 136
“Further, recent applications of drug-loaded hydrogels (Jamal et al., 2018; Cabral-Romero et al., 2020) and microfluidic conditions (Ran et al., 2019; Saha et al., 2020; Yang et al., 2020) evaluated targeted cytotoxicity.”
Platelets and tumor-associated RNA transfer
D’Ambrosi, S., Nilsson, R. J. A., & Würdinger, T. (2021) · Blood · doi:10.1182/blood.2019003978 · Cited by 116
Organ-on-a-chip technology for the study of the female reproductive system
Young, R. E., & Huh, D. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.010 · Cited by 102
Saha, B., Mathur, T., Tronolone, J. J., Chokshi, M., Lokhande, G. K., Selahi, A., Gaharwar, A. K., Afshar-Kharghan, V., Sood, A. K., Bao, G., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg5283 · Cited by 90
“This relative simplicity and a provision to do analytics is a strength of our OTME-Chip, which is also not radically different from its prior versions (20) and consistent with prior models (39).”
BackgroundMethodResultInfluentialSelf-citationStrategies for modelling endometrial diseases
Murphy, A. R., Campo, H., & Kim, J. J. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00725-z · Cited by 89
Metadata
- Authors
- Saha, B., Mathur, T., Handley, K. F., Hu, W., Afshar-Kharghan, V., Sood, A. K., & Jain, A.
- Affiliations
- Texas A&M University (US)
- Department of Gynecologic Oncology and Reproductive Medicine and
- Department of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX; and
- Texas A&M Health Science Center (US)
- ORCID
- Venue
- Blood Advances
- Publisher
- American Society of Hematology
- Published
- 2020-07-27
- Volume
- 4
- Issue
- 14
- Pages
- 3329-3342
- ISSN
- 2473-9529 (ISSN-L)
- 2473-9537
- PMC
- PMC7391144
- OpenAlex
- W3045449149
- Cited by
- 63
- References
- 47
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 9 · 2023: 14 · 2022: 8 · 2021: 8
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Blood Advances (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P50CA217685, R35CA209904, R01CA177909, P30CA016672)
- National Institute of Biomedical Imaging and Bioengineering (R21EB025945)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- ovarian cancer, organ-on-a-chip, vascular endothelium, tumor microvasculature, endothelial barrier function, vascular leakage, tumor inflammation, cytokines, atorvastatin, metastasis, microfluidic tumor model, platelet-endothelium interaction
- MeSH terms
- Animals, Blood Platelets, Endothelium, Vascular, Female, Humans, Ovarian Neoplasms, Endothelial Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: OvCa-Chip microsystem recreates vascular endothelium–mediated platelet extravasation in ovarian cancer. https://app.cochat.ai/papers/10.1182/bloodadvances.2020001632
- The paper
- Saha, B., Mathur, T., Handley, K. F., Hu, W., Afshar-Kharghan, V., Sood, A. K., & Jain, A. (2020). OvCa-Chip microsystem recreates vascular endothelium–mediated platelet extravasation in ovarian cancer. Blood Advances. https://doi.org/10.1182/bloodadvances.2020001632
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.